Department of Health and Social Care

NHS Continuing Healthcare (CHC) is a package of ongoing care that is arranged and funded solely by the National Health Service where the individual has been assessed and found to have a ‘primary health need’.

An individual has a primary health need if, having taken account of all their needs, the main aspects or majority of the care they require is focused on addressing and/or preventing health needs. In deciding whether a person has a primary health need, the integrated care board (ICB) must consider whether the support required by that person is above the limits of what the local authority can provide. Under Section 22 of the Care Act 2014, local authorities are generally prevented from meeting needs by offering services that the NHS must provide under the National Health Service Act 2006.

As far as is reasonably practicable, the ICB must consult with the relevant local authority before making any decision about an individual’s eligibility for CHC.

NHS Continuing Healthcare (CHC) is a package of ongoing care that is arranged and funded solely by the National Health Service where the individual has been assessed and found to have a ‘primary health need’.

An individual has a primary health need if, having taken account of all their needs, the main aspects or majority of the care they require is focused on addressing and/or preventing health needs. In deciding whether a person has a primary health need, the integrated care board (ICB) must consider whether the support required by that person is above the limits of what the local authority can provide. Under Section 22 of the Care Act 2014, local authorities are generally prevented from meeting needs by offering services that the NHS must provide under the National Health Service Act 2006.

As far as is reasonably practicable, the ICB must consult with the relevant local authority before making any decision about an individual’s eligibility for CHC.

Under the Care Act 2014, local authorities are tasked with the duty to shape their care markets to meet the diverse needs of all local people. This includes negotiating fees individually with care providers, including in the domiciliary market, to achieve a sustainable balance of quality, effectiveness, and value for money.

We expect local authorities to pay sustainable fee rates that meet the costs of delivering care, which is why the Market Sustainability and Improvement Fund provided over £1 billion for adult social care to local authorities over 2025/26. This can be used to target increasing fee rates paid to adult social care.

Integrated care boards (ICBs) are responsible for commissioning palliative care services to meet the reasonable needs of their population, which can include hospice services available within the ICB catchment. To support ICBs in this duty, NHS England has published statutory guidance and a service specification.

The Government is developing a Palliative Care and End-of-Life Care Modern Service Framework (MSF) for England. The MSF will drive improvements in the services that patients and their families receive at the end of life and will enable ICBs to address challenges in access, quality, and sustainability through the delivery of high-quality, personalised care.

Through our MSF, we will closely monitor the shift towards the strategic commissioning of palliative care and end-of-life care services to ensure that services reduce variation in access and quality. We will consider contracting and commissioning arrangements as part of our MSF. We recognise that there is currently a mix of contracting models in the hospice sector. By supporting ICBs to commission more strategically, we can move away from grant and block contract models. In the long term, this will aid sustainability and help hospices’ ability to plan ahead.

The recently published Strategic Commissioning Framework and Medium-Term Planning Guidance also make clear the expectations that ICBs should understand current and projected total service utilisation and costs for those at the end of life, creating an overall plan to more effectively meet these needs through neighbourhood health.

Hospices provide both core and specialist palliative care. Whilst acknowledging that not everyone will need specialist palliative care, we must ensure is that there is equitable and timely access to these services, whether they are provided by hospices or the National Health Service.

While no specific assessment has been made of the cost of changes in the levels of funding to hospices on the wider healthcare system, as part of our 10-Year Health Plan, the Government will shift the focus of healthcare out of the hospital and into the community. We recognise that it is vital to include palliative care and end-of-life care, including hospices, in this shift.

Integrated care boards (ICBs) are responsible for commissioning palliative care services to meet the reasonable needs of their population, which can include hospice services available within the ICB catchment. To support ICBs in this duty, NHS England has published statutory guidance and a service specification.

The Government is developing a Palliative Care and End-of-Life Care Modern Service Framework (MSF) for England. The MSF will drive improvements in the services that patients and their families receive at the end of life and will enable ICBs to address challenges in access, quality, and sustainability through the delivery of high-quality, personalised care.

Through our MSF, we will closely monitor the shift towards the strategic commissioning of palliative care and end-of-life care services to ensure that services reduce variation in access and quality. We will consider contracting and commissioning arrangements as part of our MSF. We recognise that there is currently a mix of contracting models in the hospice sector. By supporting ICBs to commission more strategically, we can move away from grant and block contract models. In the long term, this will aid sustainability and help hospices’ ability to plan ahead.

The recently published Strategic Commissioning Framework and Medium-Term Planning Guidance also make clear the expectations that ICBs should understand current and projected total service utilisation and costs for those at the end of life, creating an overall plan to more effectively meet these needs through neighbourhood health.

Hospices provide both core and specialist palliative care. Whilst acknowledging that not everyone will need specialist palliative care, we must ensure is that there is equitable and timely access to these services, whether they are provided by hospices or the National Health Service.

While no specific assessment has been made of the cost of changes in the levels of funding to hospices on the wider healthcare system, as part of our 10-Year Health Plan, the Government will shift the focus of healthcare out of the hospital and into the community. We recognise that it is vital to include palliative care and end-of-life care, including hospices, in this shift.

The Government has a bold ambition to raise the healthiest generation of children ever and to give every baby the best start in life. Best Start Family Hubs and Healthy Babies plays a crucial role in achieving this. We are committed to delivering the 10-Year Health Plan ambition to match Healthy Babies, formerly Start for Life, to Best Start Family Hubs over the next decade.

Healthy Babies is one element of our broader commitment to supporting babies, children, and families. From April 2026, Best Start Family Hubs will expand to every single local authority, backed by over £500 million to reach up to half a million more children and families. This funding will help all local authorities to integrate a range of statutory and non-statutory health and family services. We will continue to work in partnership with all local authorities, including those not receiving Healthy Babies funding, to support the integration and co-location of health services within Best Start Family Hub networks, laying the foundations for the future expansion of Healthy Babies services.

The 10-Year Health Plan sets out an ambitious agenda to how we will improve the nation’s health by creating a new model of care that is fit for the future.

We recognise that local authorities such as Stockport Council are ambitious, seeking to deliver universal support to babies, children, and their families and prevent escalating need. We are committed to delivering the 10-Year Health Plan ambition to match Healthy Babies, formerly Start for Life, to Best Start Family Hubs over the next decade.

Healthy Babies is one element of our broader commitment to supporting babies, children, and families. From April 2026, Best Start Family Hubs will expand to every single local authority, including Stockport Council, backed by over £500 million to reach up to half a million more children and families. This funding will help all local authorities to integrate a range of statutory and non-statutory health and family services.

I refer the Hon. Member to the answer I gave on 16 January 2026 to Question 101856.

NHS England Screening and Immunisation Teams, including a dedicated team covering Thames Valley, work closely with providers and local partners to ensure cancer screening programmes are delivered in line with national standards for quality, safety and effectiveness.

At a local level, the NHS Buckinghamshire, Oxfordshire and Berkshire West Integrated Care Board (ICB) works in partnership with NHS England, primary care, providers and the Thames Valley Cancer Alliance to support the delivery and uptake of cancer screening programmes across Buckingham and Bletchley. This includes ongoing monitoring of screening coverage and performance at place and practice level, identifying variation, and supporting action where uptake or performance falls below national standards.

At a national level, we recently announced that the NHS Bowel Cancer Screening Programme in England is lowering the faecal immunochemical test threshold from 120 micrograms of blood per gram of faeces to 80 micrograms of blood per gram of faeces. It is estimated that this change will detect approximately 600 additional bowel cancers early each year in England, approximately an 11% increase, and find 2,000 more people with high-risk polyps in their bowel, allowing doctors to remove them before they ever turn into cancers.

Additionally, in early 2026, the NHS Cervical Screening Programme will be offering a self-testing kit to under-screened women, starting with those who are the most overdue for screening. This will help tackle deeply entrenched barriers that keep some away from screening.

These national-level changes will benefit people across England, including those living in the Buckingham and Bletchley constituency.

As announced in the 10-Year Health Plan, as well as an overall quality strategy, the National Quality Board is overseeing the development of a new series of service frameworks to accelerate progress in conditions where there is potential for rapid and significant improvements in quality of care and productivity.

Early priorities include cardiovascular disease, severe mental illness, and the first ever service framework for frailty and dementia. The Government will consider other long-term conditions with significant health and economic impacts for future waves of modern service frameworks.

NHS England is delivering a comprehensive programme to improve the diagnosis, treatment, and outcomes of people with kidney disease. In 2023, NHS England published a renal services transformation toolkit to support earlier identification of chronic kidney disease and strengthen management across the whole patient pathway.

Non-alcoholic fatty liver disease is now commonly referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), although the terms are still often used interchangeably.

While the Department has not had any recent discussions with medical professionals about care for people with MASLD, NHS England has recently commenced a programme for the transformation of liver services. This programme is being led by the NHS England Hepatobiliary and Pancreas Clinical Reference Group (HPB CRG). HPB CRG is working with partners to co-produce resources to raise public knowledge and awareness of all forms of liver disease. In time, this may include incorporating liver health checks into the NHS Making Every Contact Count and NHS Health Checks initiatives.

The HPB CRG is also aiming to improve early diagnosis and intervention through developing evidence-based best-practice pathways for both primary care and referral to secondary care services. The HPB CRG is looking at access and equity of access to diagnostic tests across England and exploring the applicability of automated Fib4 tests and Intelligent Liver Function Testing, potentially utilising community diagnostic centres.

The British Society for Gastroenterology is currently updating its pathways and guidance for MASLD for both primary and secondary care, diagnostics, and treatment, which we anticipate will be published soon. There are also a number of ongoing National Institute for Health and Care Excellence assessments looking at new treatments for MASLD, including Resmetirom and Semaglutide. Outputs and recommendations are expected to be published in mid-2026.

Clinical teams also have access to NHS England’s Getting it Right First Time Advice and Guidance toolkit and templates for gastroenterology, which feature advice on managing abnormal liver function tests and MASLD. These templates enable general practitioners to seek timely advice from secondary care specialists, helping to reduce unnecessary delays.

Non-alcoholic fatty liver disease is now commonly referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), although the terms are still often used interchangeably.

While the Department has not had any recent discussions with medical professionals about care for people with MASLD, NHS England has recently commenced a programme for the transformation of liver services. This programme is being led by the NHS England Hepatobiliary and Pancreas Clinical Reference Group (HPB CRG). HPB CRG is working with partners to co-produce resources to raise public knowledge and awareness of all forms of liver disease. In time, this may include incorporating liver health checks into the NHS Making Every Contact Count and NHS Health Checks initiatives.

The HPB CRG is also aiming to improve early diagnosis and intervention through developing evidence-based best-practice pathways for both primary care and referral to secondary care services. The HPB CRG is looking at access and equity of access to diagnostic tests across England and exploring the applicability of automated Fib4 tests and Intelligent Liver Function Testing, potentially utilising community diagnostic centres.

The British Society for Gastroenterology is currently updating its pathways and guidance for MASLD for both primary and secondary care, diagnostics, and treatment, which we anticipate will be published soon. There are also a number of ongoing National Institute for Health and Care Excellence assessments looking at new treatments for MASLD, including Resmetirom and Semaglutide. Outputs and recommendations are expected to be published in mid-2026.

Clinical teams also have access to NHS England’s Getting it Right First Time Advice and Guidance toolkit and templates for gastroenterology, which feature advice on managing abnormal liver function tests and MASLD. These templates enable general practitioners to seek timely advice from secondary care specialists, helping to reduce unnecessary delays.

Improving access to diabetes technologies is a priority for NHS England, which uses routine data from the National Diabetes Audit (NDA) to help integrated care boards and providers benchmark themselves and target improvements.

The NDA 2025/26 reports that 64% of people registered as living with type 1 diabetes and eligible for Continuous Glucose Monitoring (CGM) had access to the technology and 65% of people registered as living with type 2 diabetes and eligible for CGM had access to the technology.

The eligibility criteria for CGM amongst type 2 diabetics are set in guidance published by the National Institute for Health and Care Excellence (NICE), available at the following link:

https://www.nice.org.uk/guidance/NG28

NICE is an independent body with its own processes for reviewing and updating its guidance taking account of the best available evidence of both clinical and cost effectiveness

A new diabetes technology dashboard is in development, for publication in 2026. This will allow health systems and providers to better understand access to technology and target improvement efforts, to support higher uptake of CGM for those eligible.

Improving access to diabetes technologies is a priority for NHS England, which uses routine data from the National Diabetes Audit (NDA) to help integrated care boards and providers benchmark themselves and target improvements.

The NDA 2025/26 reports that 64% of people registered as living with type 1 diabetes and eligible for Continuous Glucose Monitoring (CGM) had access to the technology and 65% of people registered as living with type 2 diabetes and eligible for CGM had access to the technology.

The eligibility criteria for CGM amongst type 2 diabetics are set in guidance published by the National Institute for Health and Care Excellence (NICE), available at the following link:

https://www.nice.org.uk/guidance/NG28

NICE is an independent body with its own processes for reviewing and updating its guidance taking account of the best available evidence of both clinical and cost effectiveness

A new diabetes technology dashboard is in development, for publication in 2026. This will allow health systems and providers to better understand access to technology and target improvement efforts, to support higher uptake of CGM for those eligible.

The UK Health Security Agency (UKHSA) monitors uptake of childhood and adolescent vaccinations via the school-based programmes and publishes this in annual coverage reports. Uptake across the programmes has shown a decline since the COVID-19 pandemic, with some evidence of stabilisation during the academic year 2023/24. The reports are available at the following link:

https://www.gov.uk/government/collections/vaccine-uptake

NHS England, in conjunction with regional colleagues, has produced a human papillomavirus (HPV) vaccination school-aged immunisation improvement and uptake plan for internal operational National Health Service use, as part of their commitment to improving vaccine coverage.

In addition, NHS England has improved digital communications on vaccinations, including expanding the NHS app, and has improved access to the HPV vaccine outside of schools through community clinics at convenient times and locations.

We will deliver the first ever Frailty and Dementia Modern Service Framework to deliver rapid and significant improvements in the quality of care and productivity. This will be informed by phase one of the independent commission into adult social care, which is expected this year.

The Frailty and Dementia Modern Service Framework will seek to reduce unwarranted variation and narrow inequality for those living with dementia and will set national standards for dementia care and redirect National Health Service priorities to provide the best possible care and support.

In developing the Modern Service Framework for Frailty and Dementia, we will be considering existing guidance, including the D100 Pathway Assessment tool, which continues the work of the Dementia Care Pathway and covers all elements of the Well Pathway from prevention through to dying well.

The Department does not hold the information requested. Each individual National Health Service trust and NHS foundation trust will publish information on the renumeration of its chair and non-executive directors as part of its annual reports and accounts which can be found on each body’s website.

The Department does not hold the information requested. Each individual National Health Service trust and NHS foundation trust will publish information on the renumeration of executive directors, including the chief executive, as part of its annual reports and accounts which can be found on each body’s website.

The Government wants a society where every person with dementia receives high-quality, compassionate care from diagnosis through to the end of life.

We will deliver the first ever Frailty and Dementia Modern Service Framework to deliver rapid and significant improvements in quality of care and productivity. This will be informed by phase one of the independent commission into adult social care, which is expected this year.

The Frailty and Dementia Modern Service Framework will seek to reduce unwarranted variation and narrow inequality for those living with dementia and will set national standards for dementia care and redirect National Health Service priorities to provide the best possible care and support.

In developing the Frailty and Dementia Modern Service Framework, we are engaging with a wide group of partners to understand what should be included, to ensure the best outcomes for people living with dementia and their families and carers. As part of this exercise, we are considering all options to help reduce variation, including reviewing metrics and targets.

The Government recognises the importance of ensuring that the National Health Service workforce is provided with high-quality training to support them to deliver quality care to patients living with obesity.

The curricula for postgraduate specialty training are developed by royal colleges and faculties and approved by the General Medical Council. Standards of education and proficiency are the responsibility of the statutorily independent professional regulators.

Individual employers are responsible for appropriate ongoing training and continuing professional development to ensure they continue to provide safe and effective care. NHS England and other organisations support employers and the NHS workforce by providing and signposting to evidence‑based training resources on weight management. These include programmes that incorporate behavioural approaches, and in some cases psychological elements, available through platforms such as e‑Learning for Healthcare, the Royal College of General Practitioners Obesity Hub, and the Strategic Centre for Obesity Professional Education programme.

The Government recognises the importance of ensuring that the National Health Service workforce is provided with high-quality training to support them to deliver quality care to patients living with obesity.

The curricula for postgraduate specialty training are developed by royal colleges and faculties and approved by the General Medical Council. Standards of education and proficiency are the responsibility of the statutorily independent professional regulators.

Individual employers are responsible for appropriate ongoing training and continuing professional development to ensure they continue to provide safe and effective care. NHS England and other organisations support employers and the NHS workforce by providing and signposting to evidence‑based training resources on weight management. These include programmes that incorporate behavioural approaches, and in some cases psychological elements, available through platforms such as e‑Learning for Healthcare, the Royal College of General Practitioners Obesity Hub, and the Strategic Centre for Obesity Professional Education programme.

In developing the Modern Service Framework for Frailty and Dementia, we are engaging with a wide group of partners to understand what should be included to ensure the best outcomes for people living with dementia. As part of this exercise, we are considering all options to help reduce variation, including reviewing metrics and targets.

The Neighbourhood Health Service will be the driving force behind our new Genomics Population Health Service; and data will increasingly allow Neighbourhood Health Services to deliver genuinely predictive and pre-emptive care, transforming our care model entirely.

NHS England already collect and publish data about people with dementia at each general practice in England, to enable National Health Service general practitioners and commissioners to make informed choices about how to plan their dementia services around patients’ needs.

The Office for Health Improvement and Disparities Dementia Intelligence Network has also developed a tool for local systems, which includes an assessment of population characteristics such as rurality and socio-economic deprivation. This enables systems to investigate local variation in diagnosis and take informed action to enhance their diagnosis rates. The tool is available via the NHS Futures Collaboration platform.

The 10-Year Health Plan sets out to make the National Health Service fit for the future, by delivering three big shifts, from hospital to care in community, from analogue to digital, and from sickness to prevention. The plan will help to address health inequalities for disabled and autistic people by improving access to care, delivering care closer to home, and supporting the development of holistic care plans for those whose needs may require support from multiple health and care providers. We want autistic people’s access to, and experience of, healthcare services to be equitable, effective, and responsive to their needs.

The plan sets out the core principle of early intervention and support, including without the need for diagnosis, including specifically for children and young people, such as those with special educational needs and disabilities (SEND). It is clear about the importance of health services working in partnership with education settings and providing children and young people with early intervention and support to avoid needs escalating, where possible, building on learning from programmes such as Early Language Support for Every Child. We will set out our proposals for SEND reform in the upcoming Schools White Paper.

NHS England continues to support local systems to use a national framework and operational guidance to deliver improved outcomes in all-age autism assessment pathways. It has published national guidance on meeting the needs of autistic adults in mental health services and, to address physical health inequalities, is currently testing a combined health check in primary care for autistic people, those with a severe mental health condition and/or those people with a learning disability.

The Autism Act 2009 places a duty on my Rt Hon. Friend, the Secretary of State for Health and Social Care, to consult on, publish, and keep under review a national strategy for meeting the needs of autistic adults in England. My Rt Hon. Friend may choose to revise the strategy, and if so, must publish it as revised.

On 23 January 2026, we published our response to the House of Lords Autism Act 2009 Inquiry Committee’s report Time to deliver: The Autism Act 2009 and the new autism strategy. We are carefully considering the report’s recommendations, as well as our approach to developing a new national autism strategy and will set out a position in due course. The current strategy will remain in effect until a revised strategy is published.

Our 10-Year Health Plan will ensure that people with complex needs are supported to be active participants in their own care. As part of this, 95% of people with complex needs or long-term conditions will have an agreed personalised care plan by 2027.

Work is currently underway to determine the definition of “complex needs” in the context of this target and how care plans will be delivered.

Neighbourhood Health Services will bring together integrated neighbourhood teams of professionals and partners closer to people’s home, including nurses, doctors, social care workers, pharmacists, health visitors, employment support, children’s services, and more, to work together to support people and places to improve their health and wellbeing.

Neighbourhood Health provides the unifying framework that brings together what is already underway across primary care, community services, urgent care, prevention, digital, estates and population health into a single, coherent model focused on improved access, experience and outcomes.

The provision of dementia health care services is the responsibility of local integrated care boards (ICBs) and may include specialist nurses. We expect ICBs to commission services based on local population needs, taking account of National Institute for Health and Care Excellence guidelines.

There are a range of sources that present data detailing how staff working in National Health Service roles are distributed across England. These published sources include, but are not limited to, information on the trust and region of staff employed by NHS trusts and integrated care boards, information on vacancies in the NHS, and information on general medical practice staff. This information is available on the NHS.UK website.

The forthcoming 10 Year Workforce Plan will set out further detail on how we will ensure the NHS has the right staff, in the right places, to deliver high quality care for patients when they need it.

Workforce planning for medical staff already means that Medical Foundation and Specialty training posts are allocated across the United Kingdom to support workforce needs, including in rural and hard to recruit areas. While some locations have historically found recruitment more challenging, we now have fewer vacancies in the Foundation Programme. NHS England is working with a number of medical schools to pilot the allocation of students directly to their local foundation schools.

The Department has not made a specific assessment. The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing clinical guidance and quality standards. NICE’s guidance on chronic kidney disease includes guidance on the use of annual urine albumin-creatine ratio tests as the preferred method to detect and monitor kidney disease. The guidance is available on NICE’s website.

The National Institute for Health and Care Excellence (NICE) evaluates all newly licensed cancer medicines and may recommend promising treatments for use through the Cancer Drugs Fund (CDF) where there is too much clinical uncertainty for routine commissioning. Under these arrangements, cancer medicines are made available to National Health Service patients for a defined period while further real‑world evidence is collected to address the uncertainties identified in NICE’s original appraisal.

At the end of the managed access period, NICE undertakes a full re‑appraisal of the medicine. This re‑appraisal considers all the evidence gathered during CDF use alongside updated clinical and cost‑effectiveness analyses. NICE then determines whether the medicine should be routinely funded by the NHS, or whether it cannot be recommended for routine commissioning. This re‑appraisal process is one of the limited circumstances in which NICE routinely re‑evaluates previous decisions.

In 2022, NICE updated its methods and replaced the earlier end‑of‑life flexibilities with the severity modifier. As a result, re‑appraisals of cancer medicines that originally entered the CDF under end‑of‑life criteria are now conducted in line with NICE’s current methods framework, ensuring consistency, fairness, and opportunity‑cost neutrality across all appraisals. NICE has recommended 96% of the medicines that it has re-appraised following a period of managed access for routine NHS use. Where NICE is unable to recommend a medicine for routine use following the period of managed access, it remains available for existing patients but is no longer routinely funded for new patients.

No formal assessment has been made to how the principles of the Armed Forces Covenant are being applied by Op COMMUNITY or local health bodies.

Op COMMUNITY was an NHS England funded pilot that concluded in March 2024. Insights from the pilot have been used to shape the new Armed Forces National Training and Education Programme, which aims to strengthen understanding across the National Health Service of the unique needs of the Armed Forces community.

The programme is now being rolled out across the NHS. Dedicated training modules for integrated care boards will be introduced in 2026. These will support local NHS staff in developing a clearer understanding of the specific health needs of the Armed Forces community and the principles underpinning the Armed Forces Covenant.

The health of women with long-term conditions is a priority for the Government.

Our 10-Year Health Plan is centred around driving three shifts in the way health care is delivered, from hospital to community, from analogue to digital, and from sickness to prevention. More tests and scans are delivered in the community, better-joint up working between services, and greater use of technology will support women in the management of long-term conditions. This will build on the work led by the pioneering women’s health hubs.

The Government is encouraging integrated care boards (ICBs) to expand the coverage of women’s health hubs and is supporting them to use what we learned from the hub pilot programme to improve local delivery of services to women and girls. The Government is backing ICBs to do this through record funding.

We are renewing the Women’s Health Strategy, to tackle enduring challenges and build on vital progress in women’s health.

The Government has no plans to set a specific target for the proportion of National Health Service doctors educated in the United Kingdom.

The Medical Training Prioritisation Bill, introduced to Parliament on 13 January 2026, delivers the Government’s commitment to prioritise UK medical graduates for foundation training places, and to prioritise UK medical graduates and other doctors with significant NHS experience for specialty training places. The bill will ensure a sustainable medical workforce that can meet the health needs of the future and give homegrown talent a path to become the next generation of NHS doctors.

We remain committed to working together across Government and with national autism charities to improve services and outcomes for autistic people.

On 23 January, we published our response to the House of Lords Autism Act 2009 Inquiry Committee’s report Time to deliver: The Autism Act 2009 and the new autism strategy. We are carefully considering the report’s recommendations as well as our approach to the national autism strategy and will set out a position, including our plans to engage with stakeholders, in due course.

This Government is empowering local leaders with the autonomy they need to provide the best services to their local community, including those with dementia. This is why we have published the D100: Assessment Tool Pathway programme, which brings together multiple resources into a single, consolidated tool. This will help simplify best practice for system leaders and help create communities and services where the best possible care and support is available to those with dementia.

We will deliver the first ever Modern Service Framework for Frailty and Dementia to deliver rapid and significant improvements in quality of care and productivity, informed by phase one of the independent commission into adult social care, which is expected this year. The framework will seek to reduce unwarranted variation and narrow inequality for those living with dementia.

Neighbourhood Health provides the unifying framework that brings together what is already underway across primary care, community services, urgent care, prevention, digital, estates and population health into a single, coherent model focused on improved access, experience and outcomes.

The Government will commission a report on the mental health impacts of a child’s terminal diagnosis on their families. This will include a review of the available evidence and cost effectiveness. It will be carried out with reference to the recently announced independent review into mental health conditions, attention deficit hyperactivity disorder, and autism, and the wider Government action to support vulnerable children suffering from trauma.

Ministers from the Department will meet with stakeholders to discuss the scope of the report. A timetable for the report will be confirmed in due course.

The Government will commission a report on the mental health impacts of a child’s terminal diagnosis on their families. This will include a review of the available evidence and cost effectiveness. It will be carried out with reference to the recently announced independent review into mental health conditions, attention deficit hyperactivity disorder, and autism, and the wider Government action to support vulnerable children suffering from trauma.

Ministers from the Department will meet with stakeholders to discuss the scope of the report. A timetable for the report will be confirmed in due course.

The Department continues to work with the systems facing the greatest challenges to embed best practice in discharge processes, improve patient flow, and ensure timely follow‑up and community support for those most at risk of complications.

For people who need further care after discharge, a multi-disciplinary care transfer hub in each area brings together National Health Service, local authority, social care, housing, and other professionals to ensure timely discharge and suitable ongoing care and support.

As part of the Better Care Fund framework for 2025/26, the NHS and local authorities in every area are encouraged to work together to review the capacity needed to support hospital discharge for people with more complex needs. This includes ensuring there is sufficient capacity to rehabilitation and recovery services to support a timely and effective discharge, or to support avoidable admissions. It is for local systems to determine the right mix of services for their population.

In 2026/27, the Better Care Fund will continue to focus on those services that are essential for integrated health and social care, such as hospital discharge, intermediate care, rehabilitation, and reablement.

The Department continues to work with the systems facing the greatest challenges to embed best practice in discharge processes, improve patient flow, and ensure timely follow‑up and community support for those most at risk of complications.

For people who need further care after discharge, a multi-disciplinary care transfer hub in each area brings together National Health Service, local authority, social care, housing, and other professionals to ensure timely discharge and suitable ongoing care and support.

As part of the Better Care Fund framework for 2025/26, the NHS and local authorities in every area are encouraged to work together to review the capacity needed to support hospital discharge for people with more complex needs. This includes ensuring there is sufficient capacity to rehabilitation and recovery services to support a timely and effective discharge, or to support avoidable admissions. It is for local systems to determine the right mix of services for their population.

In 2026/27, the Better Care Fund will continue to focus on those services that are essential for integrated health and social care, such as hospital discharge, intermediate care, rehabilitation, and reablement.

As set out in the Hughes Report, the Government is carefully considering the Patient Safety Commissioner’s (PSC’s) recommendations, including the proposed approaches to redress for those harmed by pelvic mesh. The Hughes Report did not cover patients treated with rectopexy mesh for rectal prolapse. This is because rectal prolapse does not fall within the original definition of Pelvic Organ Prolapse that the PSC and the Independent Medicines and Medical Devices Safety Review adopted, namely a pelvic organ bulging into the vagina.

However, that is not to dismiss the very real concerns of these patients. We are considering whether rectopexy mesh should be included in the scope of the work on redress, as for example, NHS England has carried out a market engagement event to understand which of its currently commissioned mesh centres would be willing to provide mesh removal surgery for colorectal patients. A decision around which centres will be designated will be made following findings from the audit of existing mesh centres.

This is a complex, cross-Government policy area involving multiple organisations. This work requires coordinated input from several departments, and we will provide a further update in due course. I met with the PSC in December 2025, to discuss progress following the Hughes Report. I have subsequently written to Dr Hughes about the actions we are undertaking to ensure service-level interventions are embedded in the National Health Service specific to making a real-life impact on those affected by pelvic mesh and valproate.

General practitioners (GPs) are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by the National Institute for Health and Care Excellence, to ensure that they can continue to provide high quality care to all patients.

We are investing an additional £1.1 billion in GPs, bringing total spend on the GP Contract to £13.4 billion in 2025/26, the biggest increase in over a decade. The 8.9% boost to the GP Contract in 2025/26 is bigger than the 5.8% growth to the National Health Service budget as a whole, demonstrating our commitment to shifting resources to the community.

The National Disease Registration Service (NDRS) in NHS England provides England’s national resource for data and analytics on cancer, rare diseases, and congenital conditions.

The NDRS already serves as a national register for women at very high risk of breast cancer. NDRS curates and quality assures the collected data to ensure sufficient accuracy and completeness. The NDRS works closely with the very high risk National Breast Screening Programme to ensure safe and robust identification of women at very high risk of cancer. The integration of this data within the wider NDRS cancer data infrastructure maximises the use of this data which helps with service planning, evaluation, and improvement, and reduces the fragmentation and siloing that would occur with standalone registers.

The National Disease Registration Service (NDRS) in NHS England provides England’s national resource for data and analytics on cancer, rare diseases, and congenital conditions.

The NDRS already serves as a national register for women at very high risk of breast cancer. NDRS curates and quality assures the collected data to ensure sufficient accuracy and completeness. The NDRS works closely with the very high risk National Breast Screening Programme to ensure safe and robust identification of women at very high risk of cancer. The integration of this data within the wider NDRS cancer data infrastructure maximises the use of this data which helps with service planning, evaluation, and improvement, and reduces the fragmentation and siloing that would occur with standalone registers.

In the Autumn Budget 2025, the Government made hard choices in order to protect the National Health Service in England and continue to prioritise reducing waiting times. We have also stepped in to cap bills and help businesses, as part of a £4.3 billion support package.

This year, we have also increased funding to community pharmacies to almost £3.1 billion, the largest uplift in funding for any part of the NHS across 2024/25 and 2025/26.

The Department will consult Community Pharmacy England on any proposed changes to reimbursement and remuneration of pharmacy contractors for 2026/27 shortly.

I refer the Hon. Member to the answer I gave to the Hon. Member for Knowsley on 6 January to Question 101055.